Correlation between overall survival and quality of life in colon cancer patients with chemotherapy

被引:1
|
作者
Murakawa, Yasuko [1 ]
Ootsuka, Kazunori [1 ]
Kusaka, Jun [2 ]
Miura, Kou [3 ]
机构
[1] Miyagi Canc Ctr, Dept Canc Chemotherapy, Nodayama 47-1, Natori, Miyagi 9811293, Japan
[2] Miyagi Canc Ctr, Dept Gastroenterol, Natori, Japan
[3] Miyagi Canc Ctr, Dept Digest Surg, Natori, Japan
关键词
Chemotherapy; Hospitalisation; Inoperable colon cancer; Outpatient consultation; Overall survival; Quality of life;
D O I
10.1186/s12885-023-10989-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundPatients presenting with inoperable colon cancer at first onset (ICF) or at time of relapse (ICR) are considered in unrecoverable. The therapeutic goal for unrecoverable cancer is to prolong overall survival (OS) and maintain a high quality of life (QOL). As data on objective indicators of QOL in cancer patients, such as length of hospitalisation (LOH), outpatient consultation times (OCT), and hospital-free survival (HFS), is limited, this study compared ICF and ICR with respect to OS and QOL over the entire clinical course.MethodsWe retrospectively evaluated 90 inoperable colon cancer patients with chemotherapy and compared ICF and ICR in terms of OS, LOH, OCT, and HFS.ResultsPatients with ICF had a worse OS than those with ICR. In patients with ICF and ICR, OS and LOH were not correlated but OS and OCT and OS and HFS were strongly correlated. In patients with ICF and ICR, OCT and HFS accounted for approximately 8% and 90% of their OS, respectively.ConclusionsThe LOH, OCT, and HFS are important factors for evaluating objective QOL of patients with inoperable colon cancer and should be considered when making treatment decisions.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Association Between Overall Survival and the Tendency for Cancer Programs to Administer Neoadjuvant Chemotherapy for Patients With Advanced Ovarian Cancer
    Melamed, Alexander
    Rauh-Hain, J. Alejandro
    Gockley, Allison A.
    Nitecki, Roni
    Ramirez, Pedro T.
    Hershman, Dawn L.
    Keating, Nancy
    Wright, Jason D.
    JAMA ONCOLOGY, 2021, : 1782 - 1790
  • [42] Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer and Overall Survival: A National Cancer Database Study
    Enofe, Nosayaba
    Morris, Andrew D.
    Liu, Yuan
    Liang, Wendi
    Wu, Christina S.
    Sullivan, Patrick S.
    Balch, Glen G.
    Staley, Charles A.
    Gillespie, Theresa W.
    Shaffer, Virginia O.
    JOURNAL OF SURGICAL RESEARCH, 2020, 252 : 69 - 79
  • [43] Association of treatment regimens with quality of life and overall survival in patients with metastatic colorectal cancer in Peru
    Namuche, Fernando
    Leon, Jorge
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [44] Correlation between response to neoadjuvant chemotherapy and survival in locally advanced breast cancer patients
    Romero, A.
    Garcia-Saenz, J. A.
    Fuentes-Ferrer, M.
    Lopez Garcia-Asenjo, J. A.
    Furio, V.
    Roman, J. M.
    Moreno, A.
    de la Hoya, M.
    Diaz-Rubio, E.
    Martin, M.
    Caldes, T.
    ANNALS OF ONCOLOGY, 2013, 24 (03) : 655 - 661
  • [45] Determinants of overall quality of life in preterminal cancer patients
    Beijer, Sandra
    Kempen, Gertrudis I. J. M.
    Pijls-Johannesma, Madelon C. G.
    de Graeff, Alexander
    Dagnelie, Pieter C.
    INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (01) : 232 - 235
  • [46] Fatigue as a Driver of Overall Quality of Life in Cancer Patients
    McCabe, Ryan M.
    Grutsch, James F.
    Braun, Donald P.
    Nutakki, Swetha B.
    PLOS ONE, 2015, 10 (06):
  • [47] Relationship between quality of life and overall survival in metastatic castration-resistant prostate cancer (mCRPC) patients in ALSYMPCA.
    Nilsson, Sten
    Sartor, A. Oliver
    Vogelzang, Nicholas J.
    Coleman, Robert E.
    O'Sullivan, Joe M.
    Shore, Neal D.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [48] Does Chemotherapy/Biologics beyond Second Line Affect Colon Cancer? Specific and Overall Survival in Metastatic Colon Cancer: An Analysis of 5,129 Patients
    Hanna, N.
    Woods, C.
    Zheng, Z.
    Onukwugha, E.
    Seal, B. S.
    Mullins, C.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S84 - S84
  • [49] ASSOCIATION BETWEEN OVERALL INCREMENTAL COST AND SURVIVAL BENEFIT OF SECOND LINE CHEMOTHERAPY/BIOLOGICS TREATMENT AMONG ELDERLY MEDICARE METASTATIC COLON CANCER PATIENTS
    Zheng, Z.
    Hanna, N. N.
    Onukwugha, E.
    Bikov, K.
    Seal, B.
    Mullins, C. D.
    VALUE IN HEALTH, 2013, 16 (03) : A139 - A139
  • [50] Effect of Chemotherapy on Overall Survival in Contemporary Metastatic Prostate Cancer Patients
    Hoeh, Benedikt
    Wuernschimmel, Christoph
    Flammia, Rocco S.
    Horlemann, Benedikt
    Sorce, Gabriele
    Chierigo, Francesco
    Tian, Zhe
    Saad, Fred
    Graefen, Markus
    Gallucci, Michele
    Briganti, Alberto
    Terrone, Carlo
    Shariat, Shahrokh F.
    Tilki, Derya
    Kluth, Luis A.
    Mandel, Philipp
    Chun, Felix K. H.
    Karakiewicz, Pierre I.
    FRONTIERS IN ONCOLOGY, 2021, 11